
### [NCIT:C26771](http://purl.obolibrary.org/obo/NCIT_C26771)
**Label:** Fallopian Tube Disorder

**Subclasses:** [NCIT:C3867](http://purl.obolibrary.org/obo/NCIT_C3867) (Fallopian Tube Carcinoma), [NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor), [NCIT:C6279](http://purl.obolibrary.org/obo/NCIT_C6279) (Fallopian Tube Endometrioid Adenocarcinoma), [NCIT:C6278](http://purl.obolibrary.org/obo/NCIT_C6278) (Fallopian Tube Gestational Choriocarcinoma), [NCIT:C40109](http://purl.obolibrary.org/obo/NCIT_C40109) (Fallopian Tube Mucinous Neoplasm), [NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma), [NCIT:C40106](http://purl.obolibrary.org/obo/NCIT_C40106) (Borderline Fallopian Tube Neoplasm), [NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor), [NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor), [NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma), [NCIT:C40126](http://purl.obolibrary.org/obo/NCIT_C40126) (Fallopian Tube Soft Tissue Neoplasm), [NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma), [NCIT:C40105](http://purl.obolibrary.org/obo/NCIT_C40105) (Stage 0 Fallopian Tube Cancer), [NCIT:C6280](http://purl.obolibrary.org/obo/NCIT_C6280) (Fallopian Tube Clear Cell Adenocarcinoma), [NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma), [NCIT:C126449](http://purl.obolibrary.org/obo/NCIT_C126449) (Serous Tubal Intraepithelial Carcinoma), [NCIT:C40102](http://purl.obolibrary.org/obo/NCIT_C40102) (Fallopian Tube Serous Neoplasm), [NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma), [NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma), [NCIT:C6282](http://purl.obolibrary.org/obo/NCIT_C6282) (Fallopian Tube Squamous Cell Carcinoma), [NCIT:C6281](http://purl.obolibrary.org/obo/NCIT_C6281) (Undifferentiated Fallopian Tube Carcinoma), [NCIT:C126464](http://purl.obolibrary.org/obo/NCIT_C126464) (Fallopian Tube Lymphoma), [NCIT:C4517](http://purl.obolibrary.org/obo/NCIT_C4517) (Benign Fallopian Tube Neoplasm), [NCIT:C115429](http://purl.obolibrary.org/obo/NCIT_C115429) (Recurrent Fallopian Tube Carcinoma), [NCIT:C26771](http://purl.obolibrary.org/obo/NCIT_C26771) (Fallopian Tube Disorder), [NCIT:C6265](http://purl.obolibrary.org/obo/NCIT_C6265) (Fallopian Tube Adenocarcinoma), [NCIT:C6267](http://purl.obolibrary.org/obo/NCIT_C6267) (Fallopian Tube Papillary Adenocarcinoma), [NCIT:C3032](http://purl.obolibrary.org/obo/NCIT_C3032) (Fallopian Tube Neoplasm), [NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor), [NCIT:C40113](http://purl.obolibrary.org/obo/NCIT_C40113) (Fallopian Tube Serous Adenofibroma), [NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma), [NCIT:C40455](http://purl.obolibrary.org/obo/NCIT_C40455) (Hereditary Fallopian Tube Carcinoma), [NCIT:C40111](http://purl.obolibrary.org/obo/NCIT_C40111) (Fallopian Tube Endometrioid Tumor), [NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma), [NCIT:C7480](http://purl.obolibrary.org/obo/NCIT_C7480) (Malignant Fallopian Tube Neoplasm), [NCIT:C126456](http://purl.obolibrary.org/obo/NCIT_C126456) (High Grade Fallopian Tube Serous Adenocarcinoma), [NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor), [NCIT:C40099](http://purl.obolibrary.org/obo/NCIT_C40099) (Fallopian Tube Serous Adenocarcinoma), [NCIT:C126457](http://purl.obolibrary.org/obo/NCIT_C126457) (Low Grade Fallopian Tube Serous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C26771](http://purl.obolibrary.org/obo/NCIT_C26771) (Fallopian Tube Disorder) 98.75%
- [NCIT:C3032](http://purl.obolibrary.org/obo/NCIT_C3032) (Fallopian Tube Neoplasm) 97.50%
- [NCIT:C7480](http://purl.obolibrary.org/obo/NCIT_C7480) (Malignant Fallopian Tube Neoplasm) 77.50%
- [NCIT:C3867](http://purl.obolibrary.org/obo/NCIT_C3867) (Fallopian Tube Carcinoma) 71.25%
- [NCIT:C6265](http://purl.obolibrary.org/obo/NCIT_C6265) (Fallopian Tube Adenocarcinoma) 62.50%
- [NCIT:C27020](http://purl.obolibrary.org/obo/NCIT_C27020) (Female Reproductive System Disorder) 61.47%
- [NCIT:C3053](http://purl.obolibrary.org/obo/NCIT_C3053) (Female Reproductive System Neoplasm) 60.22%
- [NCIT:C4875](http://purl.obolibrary.org/obo/NCIT_C4875) (Reproductive System Disorder) 60.08%
- [NCIT:C3674](http://purl.obolibrary.org/obo/NCIT_C3674) (Reproductive System Neoplasm) 58.91%
- Thing 52.73%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 52.71%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 52.59%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 52.58%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 51.39%
- [NCIT:C4913](http://purl.obolibrary.org/obo/NCIT_C4913) (Malignant Female Reproductive System Neoplasm) 40.13%


